Targeting the <scp>PTP1B‐Bcr‐Abl1</scp> interaction for the degradation of <scp>T315I</scp> mutant <scp>Bcr‐Abl1</scp> in chronic myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the PTP1B‐Bcr‐Abl1 interaction for the degradation of T315I mutant Bcr‐Abl1 in chronic myeloid leukemia

Published:2022-09-26 Issue:1 Volume:114 Page:247-258
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Elgehama Ahmed¹,Wang Yixuan¹,Yu Ying¹,Zhou Lin¹,Chen Zhixiu¹,Wang Liwei¹,Sun Lijun²,Gao Jian¹,Yu Biao³,Shen Yan¹^ORCID,Xu Qiang¹

Affiliation:

1. State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences Nanjing University Nanjing China

2. Department of Chemistry University of Science and Technology of China Hefei China

3. State Key Laborary of Bio‐organic and Natural Products Chemistry Shanghai Institute of Organic Academy Shanghai China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15580

Reference32 articles.

1. The molecular biology of chronic myeloid leukemia

2. SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl

3. Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML

4. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

5. The Growing Arsenal of ATP-Competitive and Allosteric Inhibitors of BCR–ABL: Figure 1.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversible control of kinase signaling through chemical-induced dephosphorylation;Communications Biology;2024-08-31

2. Reversible control of kinase signaling through chemical-induced dephosphorylation;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3